- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Gynaecological Malignancies
Total 1554 results
-
Loyola UniversityGamida Cell ltdCompleted
-
Duke UniversityCompletedA Controlled Study of Stem Cell Transplantation Medical Home Care Compared to Standard Hospital CareHematologic MalignanciesUnited States
-
Institut Paoli-CalmettesInnate PharmaUnknownHematologic MalignanciesFrance
-
Medical University of South CarolinaTerminatedHematological MalignanciesUnited States
-
Mitchell Horwitz, MDCompletedHematological MalignanciesUnited States
-
St. Jude Children's Research HospitalTerminated
-
Assistance Publique - Hôpitaux de ParisCompletedPatients With Advanced Lymphoid Malignancies in the Absence of an HLA Identical or Mismatch DonorFrance
-
St. Jude Children's Research HospitalGenzyme, a Sanofi CompanyCompleted
-
Dana-Farber Cancer InstituteMiltenyi Biomedicine GmbHCompletedHematologic MalignanciesUnited States
-
Instituto de Investigacion Sanitaria La FeUnknown
-
Indiana University School of MedicineGenzyme, a Sanofi CompanyCompletedHematologic MalignanciesUnited States
-
Emory UniversityCompletedHematologic Diseases | Hematologic MalignanciesUnited States
-
Emory UniversityCompleted
-
Nantes University HospitalCompleted
-
University of LiegeKU Leuven; Amgen; Vrije Universiteit BrusselCompletedHematological MalignanciesBelgium
-
Dana-Farber Cancer InstituteBrigham and Women's Hospital; AmgenCompletedHematologic MalignanciesUnited States
-
Hospital Clinic of BarcelonaUnknown
-
Charite University, Berlin, GermanyUniversity of LeipzigUnknownAcute Myeloid Leukemias | Advanced Hematological Malignancies | Indication for Allogeneic Stem Cell Transplantation | no HLA-identical Donor AvailableGermany
-
First Affiliated Hospital of Zhejiang UniversityRecruiting
-
Kah Poh LohWithdrawn
-
Kiromic, Inc.WithdrawnCancer | Hematologic MalignanciesUnited States
-
GlaxoSmithKlineWithdrawn
-
Zhejiang UniversityNot yet recruiting
-
Kangpu Biopharmaceuticals, Ltd.RecruitingHematological MalignanciesUnited States
-
Rhizen Pharmaceuticals SACompletedHematological MalignanciesUnited States, Georgia, Poland
-
medac GmbHCompletedHematological MalignanciesGermany, Finland, Poland, Sweden
-
He HuangCompletedHematologic MalignanciesChina
-
SecuraBioTerminatedHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterCompletedHematologic MalignanciesUnited States
-
Novartis PharmaceuticalsCompletedHematological MalignanciesGermany, Switzerland, France
-
M.D. Anderson Cancer CenterChiron CorporationCompletedHematologic MalignanciesUnited States
-
Fate TherapeuticsTerminatedA Phase 1 Trial of a Single ProHema® CB Product for Pediatric Patients With Hematologic MalignanciesHematologic MalignanciesUnited States
-
Dartmouth-Hitchcock Medical CenterTerminatedHematologic MalignanciesUnited States
-
Beijing Immunochina Medical Science & Technology...Unknown
-
Anne Beaven, MDNovartisWithdrawnHematologic MalignanciesUnited States
-
Ottawa Hospital Research InstituteCanadian Institutes of Health Research (CIHR); The Ottawa Hospital; Hamilton... and other collaboratorsCompletedHematologic MalignanciesCanada
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHematologic MalignanciesUnited States
-
Infinity Pharmaceuticals, Inc.Terminated
-
University Hospital TuebingenCompletedHematologic MalignanciesGermany
-
Genzyme, a Sanofi CompanyTerminatedHematologic MalignanciesUnited States
-
AgennixWithdrawn
-
Emory UniversityCompletedHematologic MalignanciesUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Azienda Ospedaliera San Giovanni BattistaCompleted
-
University Of PerugiaUnknownHematological MalignanciesItaly
-
University of Colorado, DenverCompletedMalignancies | Stenosis of VaginaUnited States
-
Esanex Inc.Completed
-
PCI Biotech ASCompletedCutaneous or Sub-cutaneous MalignanciesUnited Kingdom
-
Clavis PharmaCompletedAML | Hematologic MalignanciesUnited States, United Kingdom, France, Germany, Italy, Norway
-
Ruijin HospitalNot yet recruitingHematologic Malignancy